BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35190778)

  • 21. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
    Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
    Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Rare Case of Hyperandrogenism Due to Fibrothecoma and Leydig Cell Tumor in a Postmenopausal Woman With Adrenal Adenoma: A Case Report and Literature Review.
    Hussain A; Uy E; Marlowe S; Piercy J; Akbar A
    Cureus; 2023 Aug; 15(8):e43180. PubMed ID: 37692722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
    Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
    J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
    Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
    Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report.
    Shwana S; Shrikrishnapalasuriyar N; Yin W; Vij M; Kalhan A
    touchREV Endocrinol; 2021 Apr; 17(1):75-78. PubMed ID: 35118450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
    Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
    Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The case of the elusive androgen.
    Cobin RH
    Endocr Pract; 2002; 8(6):433-8. PubMed ID: 15260009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use of Ovarian Vein Sampling to Lateralize a Virilizing Leydig Cell Ovarian Tumor.
    Baweja K; Shuster S; Awad S
    AACE Clin Case Rep; 2023; 9(6):182-185. PubMed ID: 38045790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of pure Leydig cell ovarian tumor not visible on imaging by selective venous blood sampling in a woman with secondary amenorrhea and hirsutism: A case report.
    Oride A; Kanasaki H; Okada H; Kyo S
    Case Rep Womens Health; 2021 Apr; 30():e00298. PubMed ID: 33665140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
    Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
    Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New onset alopecia and hirsutism in a postmenopausal women.
    Bühler-Christen A; Tischler V; Diener PA; Brändle M
    Gynecol Endocrinol; 2009 May; 25(5):324-7. PubMed ID: 19903039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman.
    Chantler DJ; Gordon D; Millan D; Panarelli M
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report.
    Adefris M; Fekadu E
    J Med Case Rep; 2017 Aug; 11(1):242. PubMed ID: 28851436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virilizing ovarian Leydig cell tumor in a woman with subclinical Cushing syndrome.
    Diab DL; Faiman C; Siperstein AE; Grossman WF; Rabinowitz LO; Hamrahian AH
    Endocr Pract; 2008 Apr; 14(3):358-61. PubMed ID: 18463044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of postmenopausal virilization.
    Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked hyperandrogenicity in a 60-year-old woman.
    Aljenaee K; Ali S; Cheah SK; MacEneaney O; Mulligan N; Hickey N; Tun TK; Sreenan S; McDermott JH
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
    Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
    Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
    van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
    Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.